The new tests could help detect malaria in cases where plasmodium parasites carry gene deletions impacting traditional rapid diagnostics.

The firm presented data at AACR this week showing the improved performance of its molecular pancreatic cancer early detection assay.

The firm's collaborators presented research at AACR showing an association between ctDNA positivity and lack of pathologic ...

With the next PAMA data collection period starting in May, reporting by hospital labs in particular will be essential, but their level of participation remains uncertain.

The tests use AI-powered algorithms to analyze digital histopathology images, along with patient clinical data.

The Utrecht, Netherlands-based company recently closed a $70 million funding round and published trial results showing its technology's equivalence to manual blood collection.

At AACR, Guardant Health and a Japanese group showcased data on machine learning models that predict the tissue of origin in cancers of unknown primary.

NEW YORK — Solvd Health said on Tuesday that it has received approval from the US Food and Drug Administration to offer its AvertD pharmacogenomic test for opioid use disorder (OUD) using blood ...

Last week, readers were most interested in a story about Roche expanding the cancer testing portfolio of subsidiary Foundation Medicine by buying Saga Diagnostics.

Pathologists at academic medical centers are using intentional change-management strategies to overcome some intangible barriers digital uptake.

The companies have developed the SmartChip Biosecurity Platform, which combines Takara's instrumentation with Resistomap's software.